PHILADELPHIA, Pennsylvania, February 21, 2011 /PRNewswire-FirstCall/ --
- Issue Marks the Beginning of Their Partnership, Includes CCS Atrial Fibrillation Guidelines
Elsevier and the Canadian Cardiovascular Society (CJC) announce the publication of the January/February 2011 issue of the Canadian Journal of Cardiology (CJC), the first in their partnership. This theme issue focused on atrial fibrillation includes the long-awaited Canadian Cardiovascular Society Atrial Fibrillation Guidelines.
The CCS Atrial Fibrillation Guidelines are notable for the novel grading system adopted by the CCS. These guidelines address pathophysiology and investigation, emergency management, anti-arrhythmic drug therapy, stroke prevention, catheter ablation, prevention of postoperative atrial fibrillation, and surgical procedures to control arrhythmia.
The selection of the atrial fibrillation theme reflects the intention of Editor-in-Chief Stanley Nattel, MD, to focus on important clinical problems, with particular emphasis on knowledge translation. "The term 'translational research' is generally used for the translation of original basic research to clinical application," says Dr. Nattel. "However, the concept of 'knowledge translation' is much broader, including translation of clinical and population science to clinical application, translation of novel clinical insights and concerns into priorities in bench research, and translation of guidelines into clinical practice, as well as the classical bench-to-bedside meaning," he added.
First launched in 1985, the Canadian Journal of Cardiology began as a controlled circulation journal. The Journal has matured to become the official journal of the Canadian Cardiovascular Society (CCS) and is recognized as the voice of the specialty in Canada.
About the Canadian Journal of Cardiology (CJC)
The Canadian Journal of Cardiology (http://www.onlinecjc.ca) is the official journal of the Canadian Cardiovascular Society (http://www.ccs.ca/). It is a vehicle for the national and international dissemination of new knowledge in cardiology and cardiovascular science, particularly serving as a major venue for the results of Canadian cardiovascular research and Society guidelines. The Journal publishes original reports of clinical and basic research relevant to cardiovascular medicine as well as editorials, review articles, case reports, and papers on health outcomes, policy research, ethics, medical history, and political issues affecting practice.
About the Canadian Cardiovascular Society (CCS)
The Canadian Cardiovascular Society is the professional association for Canadian cardiovascular physicians and scientists working to promote cardiovascular health and care through knowledge translation, professional development, and leadership in health policy. The CCS provides programs and services to its 1900+ members and others in the cardiovascular community, including guidelines for cardiovascular care, the annual Canadian Cardiovascular Congress, and, with the Canadian Cardiovascular Academy, programs for trainees. More information about the CCS and its activities can be found at http://www.ccs.ca.
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com/) and Cell (http://www.cell.com/), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect (http://www.sciencedirect.com/), SciVerse Scopus (http://www.scopus.com/), Reaxys (https://www.reaxys.com/), MD Consult (http://www.mdconsult.com/) and Nursing Consult ( http://www.nursingconsult.com/), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com/) and MEDai's Pinpoint Review (http://www.medai.com/), which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier ( http://www.elsevier.com/) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (http://www.reedelsevier.com/), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Media Contact Francesca Costanzo +1-215-239-3249 F.Costanzo@elsevier.com